Glenmark Pharmaceuticals Inc., USA: Glenmark Ranitidine Tablets USP 150 mg
Recall reason: CGMP Deviations: Presence of NDMA impurity detected in product.. Recalled by Glenmark Pharmaceuticals Inc., USA. Distribution: Natiowide. Classification (Class II — potential health risk). Affected lots/NDC/dates: 7701034A 7701057A 7701058A 7701059A 7701060A 7701061A 7701071A 7701072A 7701073A 7701074A 7701105A 7701106A. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report